Loading

When Science Takes a Trust Fall: Rebuilding Confidence to Support Continued Innovation

June 24, 2026
29C
Type: Breakout Session
Focus Area: Infectious Disease and Vaccines
The role of vaccines in preventing and eradicating numerous infectious diseases is unparalleled; however, the past year has presented some new challenges for the industry, calling into question the scientific rigor behind these life-saving advances. This panel will highlight the importance of public support for scientific innovation, policies that can strengthen R&D and scientific discourse, and communication strategies to shore up confidence in science. Panelists will explore vaccines as an example, the benefits versus risks, healthcare costs, and how to help rebuild trust to support global health with perspectives from industry, government, advocacy, research, and academia.

Subtopic

Vaccine Confidence
Moderator
Phyllis Arthur, MBA
Executive Vice President & Head of Healthcare Policy & Programs
Biotechnology Innovation Organization (BIO)
Speakers
Rebecca Alvania, PhD, MA, MPH
Executive Director and Chief Executive Officer
National Foundation for Infectious Diseases
Deborah Glasser, MBA
Head, Specialty Care, North America, and U.S. Country Lead - BIO Trust in Science Working Group
Sanofi
Debra Houry, MD, MPH
Principal
DH Leadership and Strategy Solutions
Silvia Taylor, MBA
Executive Vice President, Chief Corporate Affairs Officer and Head of Novavax Sweden
Novavax

white squarewhite

BIO DOUBLE HELIX SPONSORS

Our sponsors help support BIO's mission to support and advocate for the biotechnology industry.

BIO HELIX SPONSORS

Loading